期刊文献+

反义表皮生长因子受体纳米颗粒对小鼠头颈鳞状细胞癌放疗增敏的实验

Antisense epidermal growth factor receptor nanoparticles enhanced radiosensitivity in SCC Ⅶ cells in vitro and in vivo
下载PDF
导出
摘要 目的应用反义表皮生长因子受体(epidermal growth factorreceptor,EGFR)纳米颗粒,研究阻断EGFR表达,对小鼠头颈部鳞状细胞癌(简称头颈鳞癌)敏感性的作用。方法载反义EGFR寡核苷酸纳米颗粒转染SCCⅦ细胞株,通过Western-blot研究其蛋白抑制效应。放射治疗干预后,细胞克隆试验和MTT试验检测细胞的放射敏感性,流式细胞仪检测细胞周期分布和凋亡情况;构建小鼠头颈癌荷瘤模型,瘤体注射反义EGFR纳米颗粒,予以4Gy放射治疗,观察肿瘤生长抑制情况。结果反义EGFR纳米颗粒明显抑制EGFR蛋白的表达情况;反义EGFR纳米颗粒与放疗联合降低了肿瘤细胞克隆形成能力及生长能力(P<0.05);肿瘤细胞发生G1期阻滞,细胞凋亡率增加(P<0.05)。体内实验发现反义EGFR纳米颗粒组肿瘤生长明显延缓。结论反义EGFR纳米颗粒通过下调EGFR的表达,使SCCⅦ细胞发生G1期阻滞,具有放疗增敏效应。 OBJECTIVE To evaluate the effects of antisense epidermal growth factor receptor (EGFR) nanoparticles on the radiosensitivity of head and neck squamous cell carcinoma in mice. METHODS The inhibition of EGFR was assessed by western-blot analysis. Nanoparticles encapsulated antisense EGFR oligonucleotides were transfected into SCC VII. After radiotherapy, the relative radiosensitivity of the cells was assessed in vitro by MTT and standard clonogenic assay. The proportion of apoptotic cells and cell cycle stages were analyzed by flow cytometry. C3H/He mice with SCC VII tumor heterografts were treated with antisense-EGFR-nanoparticles or radiation therapy alone. The relative radiosensitivity of the tumors was assessed in vivo by growth delay assays. RESULTS The antisense EGFR nanoparticles could inhibit the expression of EGFR. When antisense EGFR nanoparticles and radiation therapy were combined together, clonogenic assay and MTT analysis showed that the decrease of proliferation in SCC VII cells. Flow cytometry analysis revealed cell cycle arrest in G1 phase and increased proportion of apoptotic cells. SCC VII tumor heterografts grew slowly in vivo. CONCLUSION Our results showed antisense EGFR nanoparticles enhanced radiosensitivity by inhibition of EGFR-mediated mechanisms of radioresistance.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2009年第7期372-375,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 国家自然科学基金项目(30572013) 教育部博士点基金项目(20050610062) 成都市科技计划项目(05hJSWl90)联合资助
关键词 纳米技术 小鼠 头颈部肿瘤 鳞状细胞 辐射耐受性 Nanotechnology Mice Head and Neck Neoplasms Carcinoma, Squamous Cell Radiation Tolerance
  • 相关文献

参考文献12

  • 1Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer, 2005, 5: 341-354.
  • 2Olayioye MA, Neve RM, Lane HA, et al. The ErbB signalling network: receptor heterodimerization in development and cancer. EMBOJ, 2000, 19: 3159-3167.
  • 3Gale N, polysom receptor lesions. KambicV, Poljak M, et al. Chromosomes 7, 17 es and overexpression of epidermal growth factor and p53 protein in epithelial hyperplastic laryngeal Oncology, 2000, 58: 117-125.
  • 4Takes RP, Baatenburg de Jong R J, Wijffels K, et al. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. JPathot, 2001, 194: 298-302.
  • 5Baselga J, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol, 2005, 23: 2445-2459.
  • 6Baselga J, Trigo JM, Bourhis J, et al. Phase Ⅱ multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol, 2005, 23: 5568-5577.
  • 7West WH, Tauer KW, recombinant interleuk Yanne Ili JR. Constant infusion of adoptive immunotherapy ofadvanced cancer. N EnglJ Med, 1987, 316: 898-905.
  • 8Peng D, Fan Z, Lu Y, et al. Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res. 1996, 56: 3666-3669.
  • 9Wu X, Rubin M, Fan Z, et al. Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonalantibody. Oncogene, 1996, 12: 1397-1403.
  • 10Shintani S Li C, Mihara M, et al. Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa ZD1839) , an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cance. Int J Cancer, 2003, 107: 1030-1037.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部